The Quiet Exit From Medicare Advantage Hospice Contracts
Regional hospice billing groups across the country are walking away from Medicare Advantage plans – not loudly, not with press releases, but one contract at a time. The pattern is visible in billing office decisions, patient intake protocols, and the growing number of hospice providers quietly listing which insurers they no longer accept. What looks like a series of isolated business decisions is actually a coordinated response to a structural problem that has been building for years.
Medicare Advantage, the privatized alternative to traditional Medicare, now covers more than half of all Medicare enrollees. For hospice providers, that enrollment shift should mean a larger patient pool. Instead, it has become a source of operational strain serious enough that smaller and mid-sized billing groups are choosing to opt out entirely rather than absorb the administrative and financial costs of staying in-network.
Why the Math Stopped Working
Traditional Medicare reimburses hospice care at a set daily rate based on the patient’s level of care – routine home care, continuous home care, inpatient respite, or general inpatient. The rate is federally established, claims processing is relatively predictable, and denials are comparatively rare. Medicare Advantage works differently. Each plan negotiates its own rates, sets its own prior authorization requirements, and applies its own clinical criteria for approving continued hospice coverage. For a regional billing group managing contracts with four or five different MA plans, that means four or five different authorization workflows, four or five sets of documentation requirements, and four or five distinct appeals processes when claims are denied.
The authorization burden alone changes the economics. A hospice nurse or social worker spending time on prior authorization paperwork is not spending that time on patient care. Billing staff hired to manage MA plan requirements add overhead that traditional Medicare billing does not generate at the same rate. When reimbursement rates under MA contracts are also lower than the traditional Medicare benchmark – which they often are at the regional level, where smaller providers have less negotiating leverage – the net effect is more work for less revenue per patient day.
Claim denial rates under Medicare Advantage hospice contracts have drawn attention at the federal level. The Office of Inspector General has previously flagged prior authorization denials in MA plans as an area of concern, finding that a portion of denied claims later reversed on appeal would have been covered under traditional Medicare. For hospice specifically, where clinical staff are managing end-of-life care under significant emotional and logistical pressure, building an internal appeals operation is not a neutral administrative task – it pulls resources directly away from care delivery.
What Regional Groups Face That National Chains Don’t
Large national hospice chains have compliance departments, dedicated billing teams, and in some cases direct contract negotiation relationships with major MA plans. A regional group operating in one or two markets has none of that scale. When an MA plan updates its authorization criteria or switches billing platforms, a national operator absorbs that change across a specialized back-office infrastructure. A smaller regional group absorbs it with the same two or three billing staff managing everything else.
This scale gap is why the exit trend is concentrated in regional operators rather than national ones. It is not that regional hospices are less competent – many deliver care that compares favorably with larger chains. The issue is purely structural. Compliance with multiple MA plan requirements costs roughly the same amount whether a billing group serves 40 patients or 400, which means the per-patient cost of maintaining those contracts is proportionally much higher for smaller providers. At some point, the decision to drop an MA contract becomes less a strategic choice and more a financial necessity. This dynamic is not unlike what regional pain management clinics have encountered when facing disproportionate administrative pressure from insurer requirements.
The Patient Access Problem No One Is Talking About
When a hospice billing group exits a Medicare Advantage network, enrolled patients do not automatically lose access to hospice care – but their options narrow. A patient whose primary coverage is through an MA plan and whose local hospice has left that plan’s network faces a real choice: switch hospice providers to one that remains in-network, or receive care out-of-network and potentially face higher cost-sharing. For patients already navigating a terminal diagnosis and end-of-life planning, that is not a simple administrative inconvenience.
Geographic distribution makes this worse. In urban markets, a patient dropped from one hospice’s network can often find another in-network provider within a reasonable distance. In rural and semi-rural markets – where many regional hospice providers operate as the only meaningful option within a large radius – an in-network exit leaves patients with no comparable alternative. The hospice that knows a patient’s family, has been coordinating care for weeks, and has established clinical relationships may simply no longer be a covered provider under that patient’s plan.
MA plans have a financial incentive to keep hospice costs down because, unlike traditional Medicare, Medicare Advantage plans bear the financial risk for their enrollees’ care costs. Hospice care, particularly for longer-stay patients with complex diagnoses, represents a significant per-day expenditure. When plans set prior authorization criteria tightly or deny claims at higher rates, they reduce spending in the short term – but they also create the conditions that push providers out of their networks, which ultimately reduces patient access to a care model that is consistently shown to reduce unnecessary hospitalizations and emergency visits in the final months of life.
Some MA plans have begun developing hospice-specific carve-outs and alternative payment arrangements in an attempt to stabilize provider participation. These models exist in pockets, primarily in markets where a plan has enough enrollment concentration to make a specialized hospice benefit worth structuring. For the majority of regional billing groups, those arrangements are not yet available – and in the meantime, the contract exits continue at a pace that is difficult to track because no centralized reporting mechanism captures in-network departures at the provider group level. A patient calling a hospice today may not know until the intake conversation that their plan is no longer accepted, and that the provider they were referred to by their oncologist stopped taking that coverage three months ago.
